title: Combined immunosuppression with low-dose cyclosporine, mizoribine, and prednisolone.
authors.affiliation: Department of Urology, Osaka University Medical School, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Takahara
authors.forename: T
authors.initials: T
authors.lastname: Fukunishi
authors.forename: Y
authors.initials: Y
authors.lastname: Kokado
authors.forename: Y
authors.initials: Y
authors.lastname: Ichikawa
authors.forename: M
authors.initials: M
authors.lastname: Ishibashi
authors.forename: S
authors.initials: S
authors.lastname: Nagano
authors.forename: T
authors.initials: T
authors.lastname: Sonoda
mesh_terms: D003524:Cyclosporins / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006085:Graft Survival; D006801:Humans; D007668:Kidney / Q000502:physiology; D016030:Kidney Transplantation; D007970:Leukopenia / Q000150:complications; D008107:Liver Diseases / Q000150:complications; D011239:Prednisolone / Q000008:administration & dosage*; D012263:Ribonucleosides / Q000008:administration & dosage* / Q000097:blood
chemical_list: D003524:Cyclosporins; D012263:Ribonucleosides; C010052:mizoribine; D011239:Prednisolone